- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Tafenoquine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Tafenoquine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Tafenoquine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tafenoquine market has been segmented into
Powder
Pills
By Application, Tafenoquine has been segmented into:
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tafenoquine market presented in the report. This section sheds light on the sales growth of different regional and country-level Tafenoquine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tafenoquine market.
The report offers in-depth assessment of the growth and other aspects of the Tafenoquine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tafenoquine Market Share Analysis
Tafenoquine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tafenoquine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tafenoquine sales, revenue and market share for each player covered in this report.
The major players covered in Tafenoquine are:
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
Merck
BOC Sciences
Amadis Chemical Company Limited
Pharmacodia (Beijing) Co.,Ltd
Among other players domestic and global, Tafenoquine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tafenoquine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tafenoquine, with price, sales, revenue and global market share of Tafenoquine in 2018 and 2019.
Chapter 3, the Tafenoquine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tafenoquine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tafenoquine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tafenoquine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Tafenoquine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tafenoquine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Powder
1.2.3 Pills
1.3 Market Analysis by Application
1.3.1 Overview: Global Tafenoquine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Overview of Global Tafenoquine Market
1.4.1 Global Tafenoquine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline Pharmaceuticals (GSK)
2.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Details
2.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Major Business
2.1.3 GlaxoSmithKline Pharmaceuticals (GSK) SWOT Analysis
2.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Product and Services
2.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
2.2.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Details
2.2.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Major Business
2.2.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. SWOT Analysis
2.2.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Product and Services
2.2.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 J & K Scientific LTD
2.3.1 J & K Scientific LTD Details
2.3.2 J & K Scientific LTD Major Business
2.3.3 J & K Scientific LTD SWOT Analysis
2.3.4 J & K Scientific LTD Product and Services
2.3.5 J & K Scientific LTD Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 BOC Sciences
2.5.1 BOC Sciences Details
2.5.2 BOC Sciences Major Business
2.5.3 BOC Sciences SWOT Analysis
2.5.4 BOC Sciences Product and Services
2.5.5 BOC Sciences Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amadis Chemical Company Limited
2.6.1 Amadis Chemical Company Limited Details
2.6.2 Amadis Chemical Company Limited Major Business
2.6.3 Amadis Chemical Company Limited Product and Services
2.6.4 Amadis Chemical Company Limited Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pharmacodia (Beijing) Co.,Ltd
2.7.1 Pharmacodia (Beijing) Co.,Ltd Details
2.7.2 Pharmacodia (Beijing) Co.,Ltd Major Business
2.7.3 Pharmacodia (Beijing) Co.,Ltd Product and Services
2.7.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tafenoquine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tafenoquine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tafenoquine Manufacturer Market Share in 2019
3.3.2 Top 6 Tafenoquine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tafenoquine Sales, Revenue and Market Share by Regions
4.1.1 Global Tafenoquine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tafenoquine Revenue and Market Share by Regions (2015-2020)
4.2 North America Tafenoquine Sales and Growth Rate (2015-2020)
4.3 Europe Tafenoquine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tafenoquine Sales and Growth Rate (2015-2020)
4.5 South America Tafenoquine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tafenoquine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tafenoquine Sales, Revenue and Market Share by Country
5.1.1 North America Tafenoquine Sales and Market Share by Country (2015-2020)
5.1.2 North America Tafenoquine Revenue and Market Share by Country (2015-2020)
5.2 United States Tafenoquine Sales and Growth Rate (2015-2020)
5.3 Canada Tafenoquine Sales and Growth Rate (2015-2020)
5.4 Mexico Tafenoquine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tafenoquine Sales, Revenue and Market Share by Country
6.1.1 Europe Tafenoquine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tafenoquine Revenue and Market Share by Country (2015-2020)
6.2 Germany Tafenoquine Sales and Growth Rate (2015-2020)
6.3 UK Tafenoquine Sales and Growth Rate (2015-2020)
6.4 France Tafenoquine Sales and Growth Rate (2015-2020)
6.5 Russia Tafenoquine Sales and Growth Rate (2015-2020)
6.6 Italy Tafenoquine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tafenoquine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tafenoquine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tafenoquine Revenue and Market Share by Regions (2015-2020)
7.2 China Tafenoquine Sales and Growth Rate (2015-2020)
7.3 Japan Tafenoquine Sales and Growth Rate (2015-2020)
7.4 Korea Tafenoquine Sales and Growth Rate (2015-2020)
7.5 India Tafenoquine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tafenoquine Sales and Growth Rate (2015-2020)
7.7 Australia Tafenoquine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tafenoquine Sales, Revenue and Market Share by Country
8.1.1 South America Tafenoquine Sales and Market Share by Country (2015-2020)
8.1.2 South America Tafenoquine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tafenoquine Sales and Growth Rate (2015-2020)
8.3 Argentina Tafenoquine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tafenoquine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tafenoquine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tafenoquine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tafenoquine Sales and Growth Rate (2015-2020)
9.3 Turkey Tafenoquine Sales and Growth Rate (2015-2020)
9.4 Egypt Tafenoquine Sales and Growth Rate (2015-2020)
9.5 South Africa Tafenoquine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tafenoquine Sales and Market Share by Type (2015-2020)
10.2 Global Tafenoquine Revenue and Market Share by Type (2015-2020)
10.3 Global Tafenoquine Price by Type (2015-2020)
11 Global Tafenoquine Market Segment by Application
11.1 Global Tafenoquine Sales Market Share by Application (2015-2020)
11.2 Global Tafenoquine Revenue Market Share by Application (2015-2020)
11.3 Global Tafenoquine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tafenoquine Sales, Revenue and Growth Rate (2021-2025)
12.2 Tafenoquine Market Forecast by Regions (2021-2025)
12.2.1 North America Tafenoquine Market Forecast (2021-2025)
12.2.2 Europe Tafenoquine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tafenoquine Market Forecast (2021-2025)
12.2.4 South America Tafenoquine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tafenoquine Market Forecast (2021-2025)
12.3 Tafenoquine Market Forecast by Type (2021-2025)
12.3.1 Global Tafenoquine Sales Forecast by Type (2021-2025)
12.3.2 Global Tafenoquine Market Share Forecast by Type (2021-2025)
12.4 Tafenoquine Market Forecast by Application (2021-2025)
12.4.1 Global Tafenoquine Sales Forecast by Application (2021-2025)
12.4.2 Global Tafenoquine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Tafenoquine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tafenoquine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tafenoquine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Tafenoquine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GlaxoSmithKline Pharmaceuticals (GSK) Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Major Business
Table 10. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 11. GlaxoSmithKline Pharmaceuticals (GSK) SWOT Analysis
Table 12. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product and Services
Table 13. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 15. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Major Business
Table 16. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 17. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. SWOT Analysis
Table 18. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product and Services
Table 19. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. J & K Scientific LTD Basic Information, Manufacturing Base and Competitors
Table 21. J & K Scientific LTD Tafenoquine Major Business
Table 22. J & K Scientific LTD Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 23. J & K Scientific LTD SWOT Analysis
Table 24. J & K Scientific LTD Tafenoquine Product and Services
Table 25. J & K Scientific LTD Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Merck Basic Information, Manufacturing Base and Competitors
Table 27. Merck Tafenoquine Major Business
Table 28. Merck Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 29. Merck SWOT Analysis
Table 30. Merck Tafenoquine Product and Services
Table 31. Merck Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 33. BOC Sciences Tafenoquine Major Business
Table 34. BOC Sciences Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 35. BOC Sciences SWOT Analysis
Table 36. BOC Sciences Tafenoquine Product and Services
Table 37. BOC Sciences Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Amadis Chemical Company Limited Basic Information, Manufacturing Base and Competitors
Table 39. Amadis Chemical Company Limited Tafenoquine Major Business
Table 40. Amadis Chemical Company Limited Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 41. Amadis Chemical Company Limited SWOT Analysis
Table 42. Amadis Chemical Company Limited Tafenoquine Product and Services
Table 43. Amadis Chemical Company Limited Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Pharmacodia (Beijing) Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 45. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Major Business
Table 46. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Total Revenue (USD Million) (2018-2019)
Table 47. Pharmacodia (Beijing) Co.,Ltd SWOT Analysis
Table 48. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product and Services
Table 49. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Tafenoquine Sales by Manufacturer (2018-2019) (Tons)
Table 51. Global Tafenoquine Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Tafenoquine Sales by Regions (2015-2020) (Tons)
Table 53. Global Tafenoquine Sales Market Share by Regions (2015-2020)
Table 54. Global Tafenoquine Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Tafenoquine Sales by Countries (2015-2020) (Tons)
Table 56. North America Tafenoquine Sales Market Share by Countries (2015-2020)
Table 57. North America Tafenoquine Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Tafenoquine Revenue Market Share by Countries (2015-2020)
Table 59. Europe Tafenoquine Sales by Countries (2015-2020) (Tons)
Table 60. Europe Tafenoquine Sales Market Share by Countries (2015-2020)
Table 61. Europe Tafenoquine Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Tafenoquine Sales by Regions (2015-2020) (Tons)
Table 63. Asia-Pacific Tafenoquine Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Tafenoquine Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Tafenoquine Sales by Countries (2015-2020) (Tons)
Table 66. South America Tafenoquine Sales Market Share by Countries (2015-2020)
Table 67. South America Tafenoquine Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Tafenoquine Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Tafenoquine Sales by Countries (2015-2020) (Tons)
Table 70. Middle East & Africa Tafenoquine Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Tafenoquine Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Tafenoquine Revenue Market Share by Countries (2015-2020)
Table 73. Global Tafenoquine Sales by Type (2015-2020) (Tons)
Table 74. Global Tafenoquine Sales Share by Type (2015-2020)
Table 75. Global Tafenoquine Revenue by Type (2015-2020) (USD Million)
Table 76. Global Tafenoquine Revenue Share by Type (2015-2020)
Table 77. Global Tafenoquine Sales by Application (2015-2020) (Tons)
Table 78. Global Tafenoquine Sales Share by Application (2015-2020)
Table 79. Global Tafenoquine Sales Forecast by Regions (2021-2025) (Tons)
Table 80. Global Tafenoquine Market Share Forecast by Regions (2021-2025)
Table 81. Global Tafenoquine Sales Forecast by Type (2021-2025) (Tons)
Table 82. Global Tafenoquine Market Share Forecast by Type (2021-2025)
Table 83. Global Tafenoquine Sales Forecast by Application (2021-2025)
Table 84. Global Tafenoquine Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tafenoquine Picture
Figure 2. Global Sales Market Share of Tafenoquine by Type in 2019
Figure 3. Powder Picture
Figure 4. Pills Picture
Figure 5. Tafenoquine Sales Market Share by Application in 2019
Figure 6. Radical Cure of P.vivax Picture
Figure 7. P. falciparum Treatment Picture
Figure 8. Prevention of Malaria Relapse Picture
Figure 9. Global Tafenoquine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Tafenoquine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Tafenoquine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Tafenoquine Sales Market Share by Manufacturer in 2019
Figure 30. Global Tafenoquine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Tafenoquine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Tafenoquine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 35. Global Tafenoquine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Tafenoquine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Tafenoquine Revenue Market Share by Regions in 2018
Figure 38. North America Tafenoquine Sales and Growth Rate (2015-2020)
Figure 39. Europe Tafenoquine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Tafenoquine Sales and Growth Rate (2015-2020)
Figure 41. South America Tafenoquine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Tafenoquine Sales and Growth Rate (2015-2020)
Figure 43. North America Tafenoquine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Tafenoquine Sales Market Share by Countries (2015-2020)
Figure 45. North America Tafenoquine Sales Market Share by Countries in 2018
Figure 46. North America Tafenoquine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Tafenoquine Revenue Market Share by Countries in 2018
Figure 48. United States Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 49. Canada Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 50. Mexico Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 51. Europe Tafenoquine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Tafenoquine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Tafenoquine Revenue Market Share by Countries in 2019
Figure 54. Germany Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 55. UK Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 56. France Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 57. Russia Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 58. Italy Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 59. Asia-Pacific Tafenoquine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Tafenoquine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Tafenoquine Revenue Market Share by Regions 2019
Figure 62. China Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 63. Japan Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 64. Korea Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 65. India Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 66. Southeast Asia Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 67. South America Tafenoquine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Tafenoquine Sales Market Share by Countries in 2019
Figure 69. South America Tafenoquine Revenue Market Share by Countries in 2019
Figure 70. Brazil Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 71. Argentina Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 72. Middle East and Africa Tafenoquine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Tafenoquine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Tafenoquine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Tafenoquine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 77. Egypt Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 78. Turkey Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 79. South Africa Tafenoquine Sales and Growth Rate (2015-2020) (Tons)
Figure 80. Global Tafenoquine Sales and Growth Rate (2021-2025) (Tons)
Figure 81. Global Tafenoquine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Tafenoquine Market Forecast (2021-2025) (Tons)
Figure 83. Europe Sales Tafenoquine Market Forecast (2021-2025) (Tons)
Figure 84. Asia-Pacific Sales Tafenoquine Market Forecast (2021-2025) (Tons)
Figure 85. South America Sales Tafenoquine Market Forecast (2021-2025) (Tons)
Figure 86. Middle East & Africa Sales Tafenoquine Market Forecast (2021-2025) (Tons)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
